Compounds > cytidine monophosphate
Page last updated: 2024-08-17

cytidine monophosphate and Leukemia, Myelomonocytic, Acute

cytidine monophosphate has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amano, T; Chinen, Y; Hamaoka, R; Imai, Y; Itoh, H; Jozaki, K; Kurokawa, M; Nishikawa, M; Yonezawa, T1
Mori, N; Murakami, S; Nagata, K; Nakanishi, M; Nakata, K; Ogawa, R; Serino, Y; Takazawa, A; Tonai, S; Wake, A1

Other Studies

2 other study(ies) available for cytidine monophosphate and Leukemia, Myelomonocytic, Acute

ArticleYear
[Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:6

    Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Bone Marrow; Cell Count; Cytidine Monophosphate; Drug Administration Schedule; Humans; Leukemia, Myelomonocytic, Acute; Male

1995
[Successful treatment of acute myelomonocytic leukemia developed from MDS with cytarabine ocfosfate (SPAC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:3

    Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukemia, Myelomonocytic, Acute; Myelodysplastic Syndromes; Remission Induction

1995